Table 3

Univariable logistic and Cox regression analyses for clinical outcomes

OutcomenOdds or hazard ratioP
CR    
    β-2M* 60 < 1.000 .022 
    Thymidine kinase* 59 0.983 .044 
    Completion of 6 O-FC courses 61 7.027 .002 
OR    
    β-2M* 60 < 1.000 .010 
    βSPD of lymph nodes by physical exam* 61 0.983 .034 
    Completion of 6 O-FC courses 61 11.556 < .001 
PFS    
    β-2M* 60 > 1.000 .007 
    Lactate dehydrogenase* 61 1.005 .009 
    ECOG performance status 0 61 0.139 .013 
    Completion of 6 O-FC courses 61 0.138 .004 
OutcomenOdds or hazard ratioP
CR    
    β-2M* 60 < 1.000 .022 
    Thymidine kinase* 59 0.983 .044 
    Completion of 6 O-FC courses 61 7.027 .002 
OR    
    β-2M* 60 < 1.000 .010 
    βSPD of lymph nodes by physical exam* 61 0.983 .034 
    Completion of 6 O-FC courses 61 11.556 < .001 
PFS    
    β-2M* 60 > 1.000 .007 
    Lactate dehydrogenase* 61 1.005 .009 
    ECOG performance status 0 61 0.139 .013 
    Completion of 6 O-FC courses 61 0.138 .004 

SPD indicates sum of product of diameters.

*

Evaluated as continuous variables.

At baseline.

or Create an Account

Close Modal
Close Modal